PAVmed (PAVM) Accounts Payables (2015 - 2025)

PAVmed has reported Accounts Payables for 11 years, with the latest figure at $678000.0 in Q4 2025.

• For the quarter ending Q4 2025, Accounts Payables rose 3.2% year-over-year to $678000.0; the trailing twelve-month figure through Dec 2025 stood at $678000.0 (up 3.2% YoY), and the FY2025 full-year result was $678000.0, up 3.2% from the prior year.
• Accounts Payables for Q4 2025 stood at $678000.0, up from $342000.0 in the prior quarter.
• The five-year high for Accounts Payables was $8.2 million in Q1 2022, with the low at $342000.0 in Q3 2025.
• Average Accounts Payables over 5 years is $2.3 million, with a median of $1.6 million recorded in 2023.
• Year-over-year, Accounts Payables surged 334.34% in 2022 and slumped 84.72% in 2023.
• Tracing PAVM's Accounts Payables over 5 years: stood at $3.3 million in 2021, then retreated by 18.04% to $2.7 million in 2022, then sank by 33.95% to $1.8 million in 2023, then slumped by 63.21% to $657000.0 in 2024, then grew by 3.2% to $678000.0 in 2025.
• The last three Accounts Payables figures came in at $678000.0 (Q4 2025), $342000.0 (Q3 2025), and $387000.0 (Q2 2025), per Business Quant data.

Peer Comparison